Human Milk Oligosaccharides (HMOs) trials recruiting now
2 registrations that name human Milk Oligosaccharides as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
1US sites across 1 state
1
2 to 4
5 to 19
20 or more
All 2 registrations
RecruitingNCT06631937
HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants
No phase
University of Aarhus
About 334 people
Started Nov 5, 2024
In plain words A study of human Milk Oligosaccharides in people 0 days to 28 days, run by University of Aarhus. It plans to enroll about 334 people at 2 sites, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 0 days to 28 days; healthy volunteers accepted. Conditions: Healthy Infants.
All infants which parents has decided mode of feeding
The exclusion criteria are on the listing.
What it tests, as registered
Human Milk Oligosaccharides; Placebo
Registered summary
The goal of this clinical trial is to learn how a mixture of human milk oligosaccharides impacts the development of the infant microbiota, the immune maturation and how the interaction between the microbiota and immune maturation may impact both short and long term health of the infant. The full summary is on the listing.
Where, as registered
No US site; Denmark (2).
Not yet recruitingNCT06791993
Impact of Probiotics on Gut Microbiome During Antibiotic Prophylaxis in Elective Orthopedic Surgery
Phase 4
Acibadem Maslak Hospital
About 60 people
Starts Feb 1, 2025 (estimated)
In plain words A Phase 4 study of human Milk Oligosaccharides in people 18 to 65, run by Acibadem Maslak Hospital. It plans to enroll about 60 people at 6 sites, 1 of them in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 65. Conditions: Dysbiosis; Gut -microbiota; Microbiome Analysis; Probiotic; Antibiotic Prophylaxis.
Adults aged between 18 and 65 years
Scheduled for elective low-risk orthopedic surgery (carpal tunnel release, A1 pulley release, knee arthroscopic surgery).
The exclusion criteria are on the listing.
What it tests, as registered
Placebo Capsule; Probiotic with Human Milk Oligosaccharides (HMO)
Registered summary
This study aims to evaluate whether probiotics can help maintain a healthy gut microbiome in patients receiving prophylactic antibiotics during elective orthopedic surgery. Antibiotics, while effective in preventing infections, can disrupt the balance of gut bacteria, leading to dysbiosis. The study hypothesizes that the use of probiotics during the perioperative period can prevent or reduce this disruption, supporting gut health and overall well-being. The full summary is on the listing.
Where, as registered
1 US site in 1 state; also Turkey (Türkiye) (4), Thailand (1).
ClinicalTrials.gov lists 11 open registrations for this search, including ones where human Milk Oligosaccharides is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).